{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:42:19Z","timestamp":1791902539817,"version":"4.3.4"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-021790"],"award-info":[{"award-number":["INV-021790"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jcv.2025.105869","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:16:21Z","timestamp":1757092581000},"page":"105869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessing sample adequacy and clinical performance of self-collected and clinician-collected HPV specimens using internal control Ct values"],"prefix":"10.1016","volume":"181","author":[{"given":"Marianna","family":"Martinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf Sakina","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Lagheden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nordqvist Kleppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementina","family":"Cocuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Sara","family":"Arroyo M\u00fchr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcv.2025.105869_bib1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/ijgc-2022-004197","article-title":"Quality assurance in human papillomavirus testing for primary cervical screening","volume":"33","author":"Cuschieri","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"7","key":"10.1016\/j.jcv.2025.105869_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jiph.2020.01.307","article-title":"Maximizing confidence in a negative result: quantitative sample adequacy control","volume":"13","author":"Brukner","year":"2020","journal-title":"J. Infect. Public Health"},{"issue":"19","key":"10.1016\/j.jcv.2025.105869_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics14192194","article-title":"Evaluation of C-C motif chemokine receptor 5 (CCR5) as a sample adequacy control in HPV molecular diagnostics","volume":"14","author":"Njoku","year":"2024","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.jcv.2025.105869_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12905-023-02691-8","article-title":"Evaluation of the applicability of internal controls on self-collected samples for high-risk human papillomavirus is needed","volume":"23","author":"Verberckmoes","year":"2023","journal-title":"BMC Women\u2019s Health"},{"issue":"2","key":"10.1016\/j.jcv.2025.105869_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1158\/1055-9965.EPI-22-1041","article-title":"HPV-based cervical cancer screening on self-samples in the Netherlands: challenges to reach women and test performance questions","volume":"32","author":"Arbyn","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jcv.2025.105869_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jcv.2018.08.006","article-title":"VALHUDES: a protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples","volume":"107","author":"Arbyn","year":"2018","journal-title":"J. Clin. Virol."},{"issue":"3","key":"10.1016\/j.jcv.2025.105869_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European guidelines for quality assurance in cervical cancer screening. Second edition--summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jcv.2025.105869_bib8","doi-asserted-by":"crossref","DOI":"10.25259\/CMAS_03_07_2021","article-title":"The Bethesda system for reporting cervical cytology","volume":"19","author":"Pangarkar","year":"2022","journal-title":"Cytojournal"},{"issue":"1","key":"10.1016\/j.jcv.2025.105869_bib9","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jcv.2015.10.025","article-title":"HPV testing for primary cervical screening: laboratory issues and evolving requirements for robust quality assurance","volume":"76","author":"Carozzi","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2025.105869_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.104756","article-title":"The challenges of defining sample adequacy in an era of HPV based cervical screening","volume":"137","author":"Cuschieri","year":"2021","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2025.105869_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70482","article-title":"Quality assurance in cervical cancer screening: evaluation of sample adequacy in HPV DNA testing","volume":"97","author":"d'Avenia","year":"2025","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.jcv.2025.105869_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2144\/btn-2022-0084","article-title":"Influence of resuspension volume on dry sampling devices taken for human papillomavirus testing: implications for self-sampling","volume":"74","author":"Connor","year":"2023","journal-title":"Biotechniques"},{"issue":"6","key":"10.1016\/j.jcv.2025.105869_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jmoldx.2024.02.006","article-title":"Evaluation of pre-analytical variables for human papillomavirus primary screening from self-collected vaginal swabs","volume":"26","author":"Qi","year":"2024","journal-title":"J. Mol. Diagn."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225001118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225001118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:07:11Z","timestamp":1778612831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653225001118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":13,"alternative-id":["S1386653225001118"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105869","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing sample adequacy and clinical performance of self-collected and clinician-collected HPV specimens using internal control Ct values","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105869"}}